246 related articles for article (PubMed ID: 33196757)
21. Microablative fractional CO
Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
[TBL] [Abstract][Full Text] [Related]
23. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Faubion SS; Loprinzi CL; Lustberg MB
Menopause; 2021 Feb; 28(6):642-649. PubMed ID: 33534429
[TBL] [Abstract][Full Text] [Related]
25. Laser Therapy for Genitourinary Syndrome of Menopause.
Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M
Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the efficacy of fractional CO
Sindou-Faurie T; Louis-Vahdat C; Oueld Es Cheikh E; Canlorbe G; Mergui JL; Uzan C; Azaïs H
Arch Gynecol Obstet; 2021 Apr; 303(4):955-963. PubMed ID: 33179118
[TBL] [Abstract][Full Text] [Related]
27. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
Wallace SL; St Martin B; Lee K; Sokol ER
Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of CO
Angioli R; Stefano S; Filippini M; Pieralli A; Montera R; Plotti F; Gatti A; Bartolone M; Luvero D
Int J Gynecol Cancer; 2020 May; 30(5):590-595. PubMed ID: 32221022
[TBL] [Abstract][Full Text] [Related]
29. Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial.
Li FG; Maheux-Lacroix S; Deans R; Nesbitt-Hawes E; Budden A; Nguyen K; Lim CY; Song S; McCormack L; Lyons SD; Segelov E; Abbott JA
JAMA; 2021 Oct; 326(14):1381-1389. PubMed ID: 34636862
[TBL] [Abstract][Full Text] [Related]
30. Fractional CO
Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
[TBL] [Abstract][Full Text] [Related]
31. Fractional CO
Lang P; Dell JR; Rosen L; Weiss P; Karram M
Lasers Surg Med; 2017 Dec; 49(10):882-885. PubMed ID: 28881431
[TBL] [Abstract][Full Text] [Related]
32. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
33. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the safety and efficacy of a monopolar nonablative radiofrequency device for the improvement of vulvo-vaginal laxity and urinary incontinence.
Lalji S; Lozanova P
J Cosmet Dermatol; 2017 Jun; 16(2):230-234. PubMed ID: 28556393
[TBL] [Abstract][Full Text] [Related]
35. Fractional Microablative CO
Pagano T; Travaglino A; Raffone A; Vallone R; Buonfantino C; De Rosa P; Locci M; Guadagno E; Insabato L; Salvatore S; De Placido G
Lasers Surg Med; 2021 Apr; 53(4):521-527. PubMed ID: 32797701
[TBL] [Abstract][Full Text] [Related]
36. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
37. Safety evaluation of fractional CO
Di Donato V; D'Oria O; Scudo M; Prata G; Fischetti M; Lecce F; Schiavi MC; Giannini A; Muzii L; Battaglia F; Monti M; Benedetti Panici P
Maturitas; 2020 May; 135():34-39. PubMed ID: 32252962
[TBL] [Abstract][Full Text] [Related]
38. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial.
Politano CA; Costa-Paiva L; Aguiar LB; Machado HC; Baccaro LF
Menopause; 2019 Aug; 26(8):833-840. PubMed ID: 31246661
[TBL] [Abstract][Full Text] [Related]
39. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial.
Hersant B; Werkoff G; Sawan D; Sidahmed-Mezi M; Bosc R; La Padula S; Kalsoum S; Ouidir N; Meningaud JP; Belkacemi Y
Ann Chir Plast Esthet; 2020 Jul; 65(4):e23-e31. PubMed ID: 32513482
[TBL] [Abstract][Full Text] [Related]
40. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency.
Kamilos MF; Borrelli CL
Einstein (Sao Paulo); 2017; 15(4):445-451. PubMed ID: 29364367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
